e0509 Effency of triptolide-coated stent on prevent restenosis
نویسندگان
چکیده
منابع مشابه
Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis
Background—Treatment of in-stent restenosis with paclitaxel-coated balloon catheter as compared with plain balloon angioplasty has shown surprisingly low late lumen loss at 6 months and fewer major adverse cardiac events up to 2 years. We compared the efficacy and safety of a paclitaxel-coated balloon with a paclitaxel-eluting stent as the current standard of care. Methods and Results—One hundr...
متن کاملNeoatherosclerosis after paclitaxel-coated balloon angioplasty for in-stent restenosis.
I n-stent neoatherosclerosis (NA) has been reported after drug-eluting stent (DES) and bare-metal stent implanta-tion. 1 NA is not only more frequent but also occurs earlier in patients undergoing DES implantation compared with those treated with bare-metal stents. 1 This phenomenon has major potential implications because complicated NA (mainly from rupture of a thin-cap fibroatheroma) may res...
متن کاملPaclitaxel-Coated Balloon for Recalcitrant In-Drug-Eluting Stent Restenosis.
C omplete percutaneous revascularization, including the treatment of complex lesions and chronic total occlusions, has become a frequent reality in interventional cardiology. Although the overall need for repeat revascularization due to drug-eluting stent (DES) restenosis remains in singledigit levels, in highly complex forms of coronary artery disease, itmay significantly compromise the long-t...
متن کاملCoated stents to prevent restenosis in coronary heart disease
BACKGROUND In-stent-restenosis (ISR) is considered to be an essential limiting factor of stenting in coronary heart disease (CHD). The development of coated stents has raised expectations on substantial lowering restenosis after stenting with decreasing the rate of restenosis and a reduction in the rate of clinical events. OBJECTIVES The present analysis addresses the questions on medical eff...
متن کاملOverview of Intracoronary Brachytherapy for in-Stent Restenosis of a Drug-Eluting Stent
Percutaneous coronary intervention with stenting is considered recently as the most common procedure for the treatment of symptomatic coronary. The article reviewed 41 studies published during 1997-2019 on intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent. Intracoronary radiation therapy was finally confirmed in the setting of in-stent restenosis using as adjunctive th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 2010
ISSN: 1355-6037
DOI: 10.1136/hrt.2010.208967.509